Hangzhou Tigermed Consulting Co Ltd Información sobre dividendos
Hangzhou Tigermed Consulting Co Ltd tiene un dividendo anual de 0.7408 por acción, con un rendimiento del 0.00%. El dividendo se paga anualmente y la última fecha ex-dividendo fue Jun 12, 2025.
Rendimiento de dividendos
Dividendo anual
Fecha de ex-dividendos
0.00%
$0.7408
Jun 12, 2025
Frecuencia de pago
Relación de pago
Anualmente
0.00%
Historial de dividendos
Fecha de ex-dividendos
Monto en efectivo
Fecha de Registro
Fecha de Pago
Jun 12, 2025
$0.3245
Jun 13, 2025
Jul 11, 2025
Jun 7, 2024
$0.6237
Jun 11, 2024
Jul 18, 2024
May 25, 2023
$0.6156
May 29, 2023
Jul 7, 2023
May 24, 2022
$0.5796
May 25, 2022
Jun 20, 2022
Gráficos de dividendos
HTMDF Dividendos
HTMDF Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Hangzhou Tigermed Consulting Co Ltd y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Hangzhou Tigermed Consulting Co Ltd?
¿Cuál es la fecha ex-dividendo para HTMDF?
¿Con qué frecuencia paga dividendos Hangzhou Tigermed Consulting Co Ltd?
Estadísticas clave
Cierre Anterior
--
Precio de apertura
--
Rango del día
-
Rango de 52 semanas
-
Volumen
--
Volumen promedio
--
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
--
¿Qué es HTMDF?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.